Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News by ticker →AAPL news SPY news Earnings

News Feed

3 results loaded, newest first. End of these results.

News 2026-09-18 10:55 UTC

Merck gets positive EU CHMP opinion for KEYTRUDA plus Padcev in bladder cancer

Merck said the EU CHMP adopted a positive opinion recommending approval of KEYTRUDA (pembrolizumab) with Padcev (enfortumab vedotin) as perioperative treatment for adults with resectable muscle-invasive bladder cancer.

MRK

News 2026-06-24 10:49 UTC

Merck Gets EU Approval

Merck receives EC approval for Keytruda combo in bladder cancer

MRK

News 2026-06-24 10:45 UTC

MRK Gets EU Approval

MRK's KEYTRUDA and Padcev approved by European Commission for treatment of muscle-invasive bladder cancer

MRK

Search market news

Matching instruments

Merck gets positive EU CHMP opinion for KEYTRUDA plus Padcev in bladder cancer

Merck Gets EU Approval

MRK Gets EU Approval